Plasma Leukaemia Inhibitory Factor, Interluekin 6 and Soluble Interleukin 6 Receptor Levels During Cardiopulmonary Bypass with Extracorporeal Circulation

By denizot Y.   Lorgeot V.   Cornu E.   Nathan N.  

Cytokine, Vol. 10, Iss. 4, 1998-04 ,pp. : 303-306

Academic Press

Access to resources Recommend Favorite

Increased Levels of Leukaemia Inhibitory Factor (Lif) in Urine and Tissue Culture Supernatant from Human Primary Bone Tumours

By Gouin F.   Heymann D.   Raher S.   de Groote D.   Passuti N.   Daculsi G.   Godard A.  

Cytokine, Vol. 10, Iss. 2, 1998-02 ,pp. : 110-114

Academic Press

Access to resources Recommend Favorite

Effects of Leukaemia Inhibitory Factor on Embryo Implantation in the Mouse

By Cai L.Q.   Cao Y.J.   Duan E.K.  

Cytokine, Vol. 12, Iss. 11, 2000-11 ,pp. : 1676-1682

Academic Press

Access to resources Recommend Favorite

Leukaemia inhibitory factor (LIF) and oncostatin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190

By Heymann D.   Godard A.   Raher S.   Bentouimou N.   Blanchard F.   Cherel M.   Hallet M.M.   Jacques Y.  

Cytokine, Vol. 8, Iss. 3, 1996-03 ,pp. : 197-205

Academic Press

Access to resources Recommend Favorite

Renal Synthesis of Leukaemia Inhibitory Factor (Lif), under Normal and Inflammatory Conditions

By Morel D.S.   Taupin J-L.   Potier M.   deminière C.   Potaux L.   Gualde N.   Moreau J-F.  

Cytokine, Vol. 12, Iss. 3, 2000-03 ,pp. : 265-271

Academic Press

Access to resources Recommend Favorite